General HealthFact-Checked

The Silent Risk Triangle: Diabetes, Fatty Liver, and Atherosclerosis

The Silent Risk Triangle: Diabetes, Fatty Liver, and Atherosclerosis
Diabetes, fatty liver, insulin resistance, and atherosclerosis can be interconnected through metabolic dysfunction, affecting the liver, blood vessels, and heart.
Prof. Dr. Fatma Younis

Written by Prof. Dr. Fatma Younis

Scientific Development Director at HealthNato | Professor of Hepatology and Gastroenterology

Fact-checked by HealthNato Scientific Team

on September 26, 2026 at 12:30 PM

The Silent Risk Triangle: Diabetes, Fatty Liver, and Atherosclerosis

They may appear to be three separate diseases… but sometimes they are different faces of one problem that started from within

Blood sugar may be slightly elevated, the liver may contain fat, and cholesterol may not be ideal…

Yet the person may not feel anything.

No obvious pain, and no symptoms telling them that something important is happening inside the body.

And this is where the danger lies.

Because metabolic dysfunction can begin silently, while its effects gradually accumulate on the liver, blood vessels, and heart.

1. It may start with insulin resistance

When the body's cells begin responding less efficiently to insulin, the body needs to release more insulin to maintain blood sugar levels.

Over time, the body's cells become even less responsive to insulin, blood sugar rises, and the condition may progress to prediabetes and then type 2 diabetes in some people.

But the story does not stop with blood sugar. Insulin resistance is also associated with blood lipid disturbances, increased visceral fat, and fat accumulation in the liver. And this is how the “triangle” begins to appear.

Visceral fat: This is the fat that surrounds the internal organs inside the abdominal cavity, such as the liver, intestines, and pancreas. It is completely different from the subcutaneous fat that you can pinch with your hand. This fat is mainly concentrated around the abdomen (the abdominal cavity).

2. Fatty liver is not simply “fat on the liver”

MASLD is the modern name for metabolic dysfunction-associated steatotic liver disease.

Having fat in the liver may initially seem like a simple issue, but some patients may develop inflammation and fibrosis, and in advanced cases, this can progress to severe fibrosis or liver cancer.

More importantly, the problem is not limited to the liver.

This specific type of fatty liver disease is also associated with an increased risk of cardiovascular disease.

Therefore, detecting fatty liver may provide an important opportunity to identify the metabolic dysfunction behind it.

3. Then atherosclerosis develops… silently

Atherosclerosis occurs when fatty deposits accumulate within the walls of the arteries.

Over time, the arteries may become narrowed or more prone to clot formation, which can lead to a heart attack, stroke, or peripheral arterial disease.

Diabetes is one of the major independent risk factors for cardiovascular disease. Therefore, modern diabetes guidelines emphasize that managing risk factors should not focus on blood sugar alone, but should also include blood pressure, blood lipids, weight, physical activity, and other factors.

4. The real problem: you may treat one side and forget the other two

One person may focus on blood sugar…

Another on liver enzymes…

And a third on their cholesterol test.

But the body does not work in such separate compartments.

When visceral obesity, insulin resistance, diabetes, lipid disturbances, and fatty liver come together, it makes sense to look at the whole picture rather than focusing on a single test.

That is why modern approaches recommend assessing cardiovascular risk alongside liver health in people with diabetes or prediabetes, especially when overweight or obesity is also present.

5. The good news: the triangle is not a final verdict

Having one factor does not mean that a person will inevitably develop all three.

But detecting the problem early opens an important window for intervention.

Weight loss when needed, regular physical activity, resistance training, improving diet quality, controlling blood sugar, blood pressure and blood lipids, and avoiding smoking are not separate recommendations. They are parts of one strategy to protect the heart, liver, and metabolic health.

In some cases, medications may also be an essential part of this strategy, depending on each person's condition and individual risk factors.

In the end

Diabetes may not be the only problem, fatty liver may not be just an image on a scan, and high cholesterol is not merely a number on a laboratory report.

Sometimes, these three signs are different messages from the same body, warning the patient and the treating physician that there is a metabolic problem that needs to be viewed as a whole.

And the most concerning part is that this picture may develop for years without obvious symptoms.

So do not wait until your heart or liver hurts before you start paying attention to your metabolic health.

Watch the numbers… but more importantly, understand the story that connects them.

Newsletter

Get new articles in your inbox

One short email a week, no spam.

Your privacy is important to us.

Related Articles